Trials / Active Not Recruiting
Active Not RecruitingNCT06696118
Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle
Electromagnetic Transduction Therapy (EMTT) on Mid-foot Osteoarthritis: A Pilot Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Electromagnetic Transduction Therapy (EMTT) | Subjects will be treated with Electromagnetic Transduction Therapy (EMTT) using the Curamedix MAGNETOLITH device. Treatments will be administered twice per week, for four weeks. Each treatment will have the following settings: level 8, 8Hz, and 10,000 pulses andwill take about 15 to 20 minutes. Treatments will be spaced 2-3 days apart. |
Timeline
- Start date
- 2025-03-13
- Primary completion
- 2026-03-01
- Completion
- 2027-01-01
- First posted
- 2024-11-20
- Last updated
- 2026-01-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06696118. Inclusion in this directory is not an endorsement.